Physician

Raetasha Sheavette Dabney, M.D.

According to 2025 Medicare claims, Raetasha Dabney, M.D. (NPI: 1124219449) practices hematology/oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76051-3586. Dabney is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Dabney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 485 traditional Medicare patients, billed 120,710 HCPCS/CPT codes, and received $2,451,092 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 760 prescription claims across 129 beneficiaries totaling $3,607,951 in drug costs, led by Revlimid (Lenalidomide). DME data shows 24 claims. Open Payments data shows 56 records totaling $1,344. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,700 to $2,451,092. Similarly, Part D prescription costs have moved sharply higher in recent years, from $264,614 to $3,607,951. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.